Surya Pharmaceutical reported net loss of Rs 110.75 crore in the quarter ended March 2012 as against net profit of Rs 27.79 crore during the previous quarter ended March 2011. Sales declined 52.57% to Rs 211.93 crore in the quarter ended March 2012 as against Rs 446.82 crore during the previous quarter ended March 2011.
For the unaudited full year, net loss reported to Rs 37.54 crore in the year ended March 2012 as against net profit of Rs 100.16 crore during the previous year ended March 2011. Sales rose 2.32% to Rs 1637.48 crore in the year ended March 2012 as against Rs 1600.42 crore during the previous year ended March 2011.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2012 | Mar. 2011 | % Var. | Mar. 2012 | Mar. 2011 | % Var. |
| Sales | 211.93 | 446.82 | -53 | 1637.48 | 1600.42 | 2 |
| OPM % | -23.09 | 15.94 | -245 | 10.90 | 16.62 | -34 |
| PBDT | -101.71 | 38.42 | PL | -2.93 | 158.29 | PL |
| PBT | -110.75 | 34.71 | PL | -37.54 | 131.74 | PL |
| NP | -110.75 | 27.79 | PL | -37.54 | 100.16 | PL |